According to a new market research report "Angiographic Catheters Market by Application (Coronary, Endovascular, Neurology and Oncology), Geography (North America, Europe, Asia Pacific and Row), End-User Analysis (Reusage Scenario, Purchase Pattern) and Competitive Scenario - Global Forecast to 2022", the global market is projected to reach USD 1,402.8 Million by 2022 from USD 980.9 Million in 2017, at a CAGR of 7.4%.
Most companies in the angiographic catheters market adopted agreements, acquisitions, expansions, and product launches as the key business growth strategy. These strategies accounted for the largest share of the overall growth approaches mapped from 2014 to 2017. Some of the leading players who adopted these strategies include Boston Scientific (US), Medtronic (US), Terumo Medical (Japan), and Cardinal Health (US).
Medtronic (US) held the leading position in the angiographic catheters market in 2016. The company adopts organic growth strategies such as product launches in order to strengthen its position in the market. For instance, in 2017, the company launched DxTerity diagnostic angiography catheter product line, which includes DxTerity TRA, InTRAkit access kit, and TRAcelet compression device. These product launches enhance the company’s product portfolio and brand recognition.
Major industry players launched innovative products to maintain and improve their position in the angiographic catheters market. Medtronic (US), Boston Scientific (US), Terumo Medical (Japan), Cardinal Health (US), and Merit Medical System (US) have been identified as key players operating in this market. These companies have broad product portfolios with comprehensive features. These players are observed to have a wide distribution network across the globe, which enhances their geographic presence.
